Please assess the completion status of the following clinical trial:

Trial Title: Non-pharmacological Analgesia During Heel Prick

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy term neonates (37-41+6 weeks of gestation) confirmed through a routine physical exam during the first 24h of life~* Wish to breastfeed~* Absence of feeding during the previous 60 minutes.~Exclusion Criteria:~* Maternal use of opioids.~* Birth in general anesthesia.~* Artificial feeding.~* Previous capillar or venous sampling.~* Previous admission to the neonatal unit.

- Gender: ALL
- Minimum Age: 37 Weeks
- Maximum Age: 41 Weeks
- Healthy Volunteers: t

Study Arms:
- Breastfeeding + skin-to-skin contact (Type: EXPERIMENTAL): In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; breastfeeding (BF) was started at least 5 minutes before heel lance and maintained during sampling
- Sucrose + skin-to-skin contact (Type: EXPERIMENTAL): In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance.
- Skin-to-skin contact (Type: EXPERIMENTAL): In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given.
- Sucrose (Type: ACTIVE_COMPARATOR): In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother

Based on this trial design, predict the completion outcome and termination type (if applicable).